1-4 of 4
Petter S. Woll, MS
Close
Sort by
Journal Articles

NK Cells Derived from Human Embryonic Stem Cells Demonstrate More Effective In Vivo Clearance of Xenografted Human Tumor Cells Compared to NK Cells Derived from Cord Blood.

Petter S. Woll, MS, Rebecca Marcus, Dan S. Kaufman, M.D., Ph.D.
Journal: Blood
Blood (2007) 110 (11): 2745.
https://doi.org/10.1182/blood.V110.11.2745.2745
Published: 2007
Journal Articles

Characterization of Hematopoietic Progenitor Cells Derived from Human Embryonic Stem Cells That Differentiate into Natural Killer Cells Capable of In Vivo Anti-Tumor Activity.

Petter S. Woll, MS, Colin H. Martin, Ph.D., Dan S. Kaufman, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 645.
https://doi.org/10.1182/blood.V108.11.645.645
Published: 2006
Journal Articles

Human Embryonic Stem Cells Differentiate into Functional Natural Killer Cells with the Capacity To Mediate Anti-Tumor Activity.

Dan S. Kaufman, MD, PhD, Petter S. Woll, MS, Colin H. Martin, PhD, Jeffrey S. Miller, MD
Journal: Blood
Blood (2005) 106 (11): 763.
https://doi.org/10.1182/blood.V106.11.763.763
Published: 2005
Journal Articles

CD34+ Cells Derived from Human Embryonic Stem Cells Demonstrate Hematopoietic Stem Cell Potential In Vitro and in Vivo.

Dan S. Kaufman, MD, PhD, Petter S. Woll, MS, Colin H. Martin, PhD, Jon L. Linehan, BS, Xinghui Tian, PhD
Journal: Blood
Blood (2004) 104 (11): 564.
https://doi.org/10.1182/blood.V104.11.564.564
Published: 2004